<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://ltrc.sciwiki.in/index.php?action=history&amp;feed=atom&amp;title=AM-1241</id>
	<title>AM-1241 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://ltrc.sciwiki.in/index.php?action=history&amp;feed=atom&amp;title=AM-1241"/>
	<link rel="alternate" type="text/html" href="https://ltrc.sciwiki.in/index.php?title=AM-1241&amp;action=history"/>
	<updated>2026-10-17T21:25:45Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://ltrc.sciwiki.in/index.php?title=AM-1241&amp;diff=6459&amp;oldid=prev</id>
		<title>Digantasen: ইংরেজি উইকিপিডিয়ার “AM-1241” নিবন্ধের বাংলা অনুবাদ</title>
		<link rel="alternate" type="text/html" href="https://ltrc.sciwiki.in/index.php?title=AM-1241&amp;diff=6459&amp;oldid=prev"/>
		<updated>2026-10-15T08:39:08Z</updated>

		<summary type="html">&lt;p&gt;ইংরেজি উইকিপিডিয়ার “AM-1241” নিবন্ধের বাংলা অনুবাদ&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
! colspan=&amp;quot;2&amp;quot; | তথ্যছক&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;verifiedfields&amp;#039;&amp;#039;&amp;#039; || changed&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;verifiedrevid&amp;#039;&amp;#039;&amp;#039; || 477235775&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;iupac_name&amp;#039;&amp;#039;&amp;#039; || (2-Iodo-5-nitrophenyl)-[1-[(1-methylpiperidin-2-yl)methyl]indol-3-yl]methanone&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;pregnancy_au&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!-- A / B1 / B2 / B3 / C / D / X --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;pregnancy_us&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!-- A / B            / C / D / X --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_au&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_ca&amp;#039;&amp;#039;&amp;#039; || Schedule II&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_de&amp;#039;&amp;#039;&amp;#039; || NpSG&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_uk&amp;#039;&amp;#039;&amp;#039; || PSA&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;legal_us&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V --&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;routes_of_administration&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;excretion&amp;#039;&amp;#039;&amp;#039; || &amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;iuphar_ligand&amp;#039;&amp;#039;&amp;#039; || 3316&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;cas_number_ref&amp;#039;&amp;#039;&amp;#039; || ??&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;cas_number&amp;#039;&amp;#039;&amp;#039; || 444912-48-5&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;unii_ref&amp;#039;&amp;#039;&amp;#039; || FDA&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;unii&amp;#039;&amp;#039;&amp;#039; || DLM851L3RD&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;pubchem&amp;#039;&amp;#039;&amp;#039; || 10141893&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;drugbank_ref&amp;#039;&amp;#039;&amp;#039; || drugbank&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;chemspiderid_ref&amp;#039;&amp;#039;&amp;#039; || chemspider&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;chemspiderid&amp;#039;&amp;#039;&amp;#039; || 8317404&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;chembl_ref&amp;#039;&amp;#039;&amp;#039; || EBI&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;chembl&amp;#039;&amp;#039;&amp;#039; || 408430&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;c&amp;#039;&amp;#039;&amp;#039; || 22&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;h&amp;#039;&amp;#039;&amp;#039; || 22&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;i&amp;#039;&amp;#039;&amp;#039; || 1&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;n&amp;#039;&amp;#039;&amp;#039; || 3&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;o&amp;#039;&amp;#039;&amp;#039; || 3&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;smiles&amp;#039;&amp;#039;&amp;#039; || Ic2ccc(N(=O)=O)cc2C(=O)c(c4ccccc14)cn1CC3CCCCN3C&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;stdinchi_ref&amp;#039;&amp;#039;&amp;#039; || chemspider&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;stdinchi&amp;#039;&amp;#039;&amp;#039; || 1S/C22H22IN3O3/c1-24-11-5-4-6-16(24)13-25-14-19(17-7-2-3-8-21(17)25)22(27)18-12-15(26(28)29)9-10-20(18)23/h2-3,7-10,12,14,16H,4-6,11,13H2,1H3&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;stdinchikey_ref&amp;#039;&amp;#039;&amp;#039; || chemspider&lt;br /&gt;
|-&lt;br /&gt;
| &amp;#039;&amp;#039;&amp;#039;stdinchikey&amp;#039;&amp;#039;&amp;#039; || ZUHIXXCLLBMBDW-UHFFFAOYSA-N&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;AM-1241&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;1-(methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole&amp;#039;&amp;#039;&amp;#039;) হলো [[wikipedia:Aminoalkylindole|aminoalkylindole]] পরিবারের একটি রাসায়নিক যৌগ, যা [[ক্যানাবিনয়েড রিসেপ্টর|cannabinoid receptor]] [[ক্যানাবিনয়েড রিসেপ্টর ২|CB&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;]]-এর একটি শক্তিশালী এবং নির্বাচনী [[অ্যাগোনিস্ট|agonist]] হিসেবে কাজ করে।&amp;lt;ref name=&amp;quot;pmid16894349&amp;quot;&amp;gt;(September 2006). &amp;quot;In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?&amp;quot;. &amp;#039;&amp;#039;British Journal of Pharmacology&amp;#039;&amp;#039;. 149 (2) 145–54. doi:[https://doi.org/10.1038/sj.bjp.0706838 10.1038/sj.bjp.0706838].&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid17549048&amp;quot;&amp;gt;(August 2007). &amp;quot;Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers&amp;quot;. &amp;#039;&amp;#039;British Journal of Pharmacology&amp;#039;&amp;#039;. 151 (7) 1061–70. doi:[https://doi.org/10.1038/sj.bjp.0707303 10.1038/sj.bjp.0707303].&amp;lt;/ref&amp;gt; CB&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; রিসেপ্টরের ক্ষেত্রে এর [[বিয়োজন ধ্রুবক|K&amp;lt;sub&amp;gt;i&amp;lt;/sub&amp;gt;]] মান ৩.৪ nM এবং এটি সংশ্লিষ্ট [[ক্যানাবিনয়েড রিসেপ্টর ১|CB&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt;]] রিসেপ্টরের তুলনায় ৮০ গুণ বেশি নির্বাচনী।&amp;lt;ref name=&amp;quot;pmid12917492&amp;quot;&amp;gt;(September 2003). &amp;quot;Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS&amp;quot;. &amp;#039;&amp;#039;Proceedings of the National Academy of Sciences of the United States of America&amp;#039;&amp;#039;. 100 (18) 10529–33. doi:[https://doi.org/10.1073/pnas.1834309100 10.1073/pnas.1834309100].&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid18289088&amp;quot;&amp;gt;(2008). &amp;quot;Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor&amp;quot;. &amp;#039;&amp;#039;Current Topics in Medicinal Chemistry&amp;#039;&amp;#039;. 8 (3) 187–204. doi:[https://doi.org/10.2174/156802608783498014 10.2174/156802608783498014].&amp;lt;/ref&amp;gt; প্রাণীদের ওপর করা গবেষণায় এটি [[ব্যথানাশক|analgesic]] (ব্যথানাশক) প্রভাব দেখিয়েছে, বিশেষ করে &amp;quot;অস্বাভাবিক&amp;quot; ব্যথা যেমন [[wikipedia:Hyperalgesia|hyperalgesia]] এবং [[wikipedia:Allodynia|allodynia]]-এর ক্ষেত্রে।&amp;lt;ref name=&amp;quot;pmid16553616&amp;quot;&amp;gt;(March 2006). &amp;quot;CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms&amp;quot;. &amp;#039;&amp;#039;The European Journal of Neuroscience&amp;#039;&amp;#039;. 23 (6) 1530–8. doi:[https://doi.org/10.1111/j.1460-9568.2006.04684.x 10.1111/j.1460-9568.2006.04684.x].&amp;lt;/ref&amp;gt; ধারণা করা হয় যে, এটি CB&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;-এর মাধ্যমে অন্তঃসত্ত্বা [[wikipedia:Opioid peptide|opioid peptide]]-এর প্রান্তীয় নিঃসরণ এবং [[wikipedia:Transient receptor potential cation channel, member A1|TRPA1 channel]]-কে সরাসরি সক্রিয় করার মাধ্যমে কাজ করে।&amp;lt;ref name=&amp;quot;pmid15705714&amp;quot;&amp;gt;(February 2005). &amp;quot;CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids&amp;quot;. &amp;#039;&amp;#039;Proceedings of the National Academy of Sciences of the United States of America&amp;#039;&amp;#039;. 102 (8) 3093–8. doi:[https://doi.org/10.1073/pnas.0409888102 10.1073/pnas.0409888102].&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid18234885&amp;quot;&amp;gt;(January 2008). &amp;quot;Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation&amp;quot;. &amp;#039;&amp;#039;The Journal of Neuroscience&amp;#039;&amp;#039;. 28 (5) 1064–75. doi:[https://doi.org/10.1523/JNEUROSCI.1565-06.2008 10.1523/JNEUROSCI.1565-06.2008].&amp;lt;/ref&amp;gt; প্রাণীদের মডেলে [[wikipedia:Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis]] (ALS) চিকিৎসাতেও এটি কার্যকারিতা প্রদর্শন করেছে।&amp;lt;ref name=&amp;quot;pmid16781706&amp;quot;&amp;gt;(August 2006). &amp;quot;AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis&amp;quot;. &amp;#039;&amp;#039;European Journal of Pharmacology&amp;#039;&amp;#039;. 542 (1–3) 100–5. doi:[https://doi.org/10.1016/j.ejphar.2006.05.025 10.1016/j.ejphar.2006.05.025].&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid17241118&amp;quot;&amp;gt;(April 2007). &amp;quot;The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset&amp;quot;. &amp;#039;&amp;#039;Journal of Neurochemistry&amp;#039;&amp;#039;. 101 (1) 87–98. doi:[https://doi.org/10.1111/j.1471-4159.2006.04346.x 10.1111/j.1471-4159.2006.04346.x].&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==হাড়ের ক্যান্সারের মডেলে প্রভাব==&lt;br /&gt;
একটি [[wikipedia:Murine|murine]] (ইঁদুর সংক্রান্ত) হাড়ের ক্যান্সারের মডেলে AM-1241-এর অ্যান্টিহাইপারালজেসিক (ব্যথা উপশমকারী) প্রভাব অনুসন্ধান করা হয়েছিল। ইঁদুরের ফিমারে [[wikipedia:Sarcoma|Sarcoma]] কোষ ইনজেকশন করার পর, তাদের দিনে দুবার AM-1241 দেওয়া হয়। AM-1241-এর চিকিৎসায় স্বতঃস্ফূর্ত এবং উদ্ভূত উভয় ধরনের ব্যথাই হ্রাস পায়, পাশাপাশি টিউমারের কারণে হাড়ের ক্ষয় এবং পরবর্তী ফ্র্যাকচারও কমে যায়। CB&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; অ্যান্টাগোনিস্ট [[SR-144,528|SR-144,528]] দিয়ে আগে থেকে চিকিৎসা করলে তা স্বতঃস্ফূর্ত এবং উদ্ভূত ব্যথার ওপর AM-1241-এর তীব্র প্রভাবকে প্রতিহত করে, যদিও এটি নিজে কোনো প্রভাব ফেলে না।&amp;lt;ref name=Lozano&amp;gt;(April 2010). &amp;quot;A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss&amp;quot;. &amp;#039;&amp;#039;Life Sciences&amp;#039;&amp;#039;. 86 (17–18) 646–53. doi:[https://doi.org/10.1016/j.lfs.2010.02.014 10.1016/j.lfs.2010.02.014].&amp;lt;!--|access-date=18 December 2011--&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== আরও দেখুন ==&lt;br /&gt;
* [[AM-1220|AM-1220]]&lt;br /&gt;
* [[AM-1248|AM-1248]]&lt;br /&gt;
* [[AM-2233|AM-2233]]&lt;br /&gt;
&lt;br /&gt;
== তথ্যসূত্র ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&amp;#039;&amp;#039;উৎস:&amp;#039;&amp;#039; ইংরেজি উইকিপিডিয়ার “AM-1241” নিবন্ধের অনুবাদ।&lt;br /&gt;
&amp;#039;&amp;#039;মূল নিবন্ধ:&amp;#039;&amp;#039; https://en.wikipedia.org/wiki/AM-1241&lt;br /&gt;
&amp;#039;&amp;#039;এই অনুবাদটি স্বয়ংক্রিয়ভাবে প্রস্তুত করা হয়েছে।&amp;#039;&amp;#039;&lt;/div&gt;</summary>
		<author><name>Digantasen</name></author>
	</entry>
</feed>